Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

New data presented at ESMO for multi-cancer early detection

Working to improve global cancer care access in low middle-income countries

Low-dose nivolumab leads to improved overall survival for head and neck cancer patients

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies

ASCO and WHO to collaborate on quality indicators for cancer facilities

Spotlight on global cancer control at ASCO 2022

ASCO 2022: Head and neck cancer highlights

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Avasopasem produces significant improvement of severe oral mucositis in head and neck patients